Logo-ijhpm
Commentary

1. New Health Technologies: A UK Perspective Comment on “Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies”
Nassim Parvizi*, Sahar Parvizi
Int J Health Policy Manag. 2017;6(12): 721-722. doi: 10.15171/ijhpm.2017.59
PMCID: PMC5726322     PMID: 29172379    
Article
PDF
XML
Cited By:
Perspective

2. Challenges and Prospects for Integrating the Assessment of Health Impacts in the Licensing Process of Large Capital Project in Brazil
Sandra de Souza Hacon, André Reynaldo Santos Périssé, Jean Simos, Nicola Luca Cantoreggi, Mirko Severin Winkler*
Int J Health Policy Manag. 2018;7(10): 885-888. doi: 10.15171/ijhpm.2018.58
PMCID: PMC6186471     PMID: 30316240    
Article
PDF
XML
Cited By:
Commentary

3. WHO FCTC as a Pioneering and Learning Instrument Comment on “The Legal Strength of International Health Instruments - What It Brings to Global Health Governance?”
Pekka Puska*
Int J Health Policy Manag. 2018;7(1): 75-77. doi: 10.15171/ijhpm.2017.63
PMCID: PMC5745870     PMID: 29325405    
Article
PDF
XML
Cited By:
Commentary

4. The Bright Elusive Butterfly of Value in Health Technology Development Comment on “Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies”
Trisha Greenhalgh*, Nick Fahy, Sara Shaw
Int J Health Policy Manag. 2018;7(1): 81-85. doi: 10.15171/ijhpm.2017.65
PMCID: PMC5745872     PMID: 29325407    
Article
PDF
XML
Cited By:
Original Article

5. Including Health in Environmental Assessments of Major Transport Infrastructure Projects: A Documentary Analysis
Emily Riley*, Patrick Harris, Jennifer Kent, Peter Sainsbury, Anna Lane, Fran Baum
Int J Health Policy Manag. 2018;7(2): 144-153. doi: 10.15171/ijhpm.2017.55
PMCID: PMC5819374     PMID: 29524938    
Article
PDF
XML
Cited By:
Systematic Reviews

6. The International Landscape of Medical Licensing Examinations: A Typology Derived From a Systematic Review
Tristan Price, Nick Lynn, Lee Coombes, Martin Roberts, Tom Gale, Sam Regan de Bere, Julian Archer*
Int J Health Policy Manag. 2018;7(9): 782-790. doi: 10.15171/ijhpm.2018.32
PMCID: PMC6186476     PMID: 30316226    
Article
PDF
XML
Cited By:
Original Article

7. Inclusion of Health in Environmental Impact Assessment of Major Transport Infrastructure Projects in Vietnam
Tracy Pham, Emily Riley*, Patrick Harris
Int J Health Policy Manag. 2018;7(9): 828-835. doi: 10.15171/ijhpm.2018.36
PMCID: PMC6186477     PMID: 30316231    
Article
PDF
XML
Cited By:
Original Article

8. Evaluation of Transition to Electronic Prescriptions in Turkey: Perspective of Family Physicians 
Sinan Bulut*, Ahmet Yıldız, Sıdıka Kaya
Int J Health Policy Manag. 2019;8(1): 40-48. doi: 10.15171/ijhpm.2018.89
PMCID: PMC6358642     PMID: 30709101    
Article
PDF
XML
Cited By:
Commentary

9. Disease Control Priorities Third Edition: Time to Put a Theory of Change Into Practice Comment on “Disease Control Priorities Third Edition Is Published: A Theory of Change Is Needed for Translating Evidence to Health Policy”
Wanrudee Isaranuwatchai, Ryan Li, Amanda Glassman, Yot Teerawattananon, Anthony J. Culye, Kalipso Chalkidou*
Int J Health Policy Manag. 2019;8(2): 132-135. doi: 10.15171/ijhpm.2018.115
PMCID: PMC6462203     PMID: 30980627    
Article
PDF
XML
Cited By:
Original Article

10. Assessment of Public Hospital Governance in Romania: Lessons From 10 Case Studies
Antonio Duran, Tata Chanturidze*, Adrian Gheorghe, Antonio Moreno
Int J Health Policy Manag. 2019;8(4): 199-210. doi: 10.15171/ijhpm.2018.120
PMCID: PMC6499904     PMID: 31050965    
Article
PDF
XML
Cited By:
Commentary

11. High Stakes Require More Than Just Talk: What to Do About Corruption in Health Systems Comment on “We Need to Talk About Corruption in Health Systems”
Taryn Vian* ORCID
Int J Health Policy Manag. 2019;8(8): 505-507. doi: 10.15171/ijhpm.2019.33
PMCID: PMC6706962     PMID: 31441292    
Article
PDF
XML
Cited By:
Original Article

12. Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling
Janneke P.C. Grutters* ORCID, Tim Govers ORCID, Jorte Nijboer Nijboer, Marcia Tummers ORCID, Gert Jan van der Wilt ORCID, Maroeska M. Rovers
Int J Health Policy Manag. 2019;8(10): 575-582. doi: 10.15171/ijhpm.2019.36
PMCID: PMC6819627     PMID: 31657184    
Article
PDF
Suppl 1
Suppl 2
XML
Cited By:
Commentary

13. Nurturing Societal Values in and Through Health Innovations Comment on “What Health System Challenges Should Responsible Innovation in Health Address?” 
Payam Abrishami*, Sjoerd Repping ORCID
Int J Health Policy Manag. 2019;8(10): 613-615. doi: 10.15171/ijhpm.2019.57
PMCID: PMC6819623     PMID: 31657189    
Article
PDF
XML
Cited By:
Commentary

14. Demystify False Dilemmas to Speak About Corruption in Health Systems: Different Actors, Different Perspectives, Different Strategies Comment on “We Need to Talk About Corruption in Health Systems”
Karen Hussmann*
Int J Health Policy Manag. 2019;8(10): 620-622. doi: 10.15171/ijhpm.2019.61
PMCID: PMC6819629     PMID: 31657191    
Article
PDF
XML
Cited By:
Commentary

15. Modeling in Early Stages of Technology Development: Is an Iterative Approach Needed? Comment on “Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling”
Michael F. Drummond*
Int J Health Policy Manag. 2020;9(6): 260-262. doi: 10.15171/ijhpm.2019.118
PMCID: PMC7382911     PMID: 32613795    
Article
PDF
XML
Cited By:
Commentary

16. Use of Evidence-Informed Deliberative Processes – Learning by Doing Comment on “Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe”
Anthony J. Culyer* ORCID
Int J Health Policy Manag. 2020;9(6): 263-265. doi: 10.15171/ijhpm.2019.116
PMCID: PMC7382906     PMID: 32613796    
Article
PDF
XML
Cited By:
Commentary

17. Characterizing the Validity and Real-World Utility of Health Technology Assessments in Healthcare: Future Directions Comment on “Problems and Promises of Health Technologies: The Role of Early Health Economic Modelling”
Nadine K. Zawadzki* ORCID, Joel W. Hay ORCID
Int J Health Policy Manag. 2020;9(8): 352-355. doi: 10.15171/ijhpm.2019.132
PMCID: PMC7500389     PMID: 32613807    
Article
PDF
XML
Cited By:
Study Protocol

18. Integrating the Population Perspective into Health System Performance Assessment (IPHA): Study Protocol for a Cross-Sectional Study in Germany Linking Survey and Claims Data of Statutorily and Privately Insured
Miriam Blümel* ORCID, Julia Röttger, Julia Köppen, Katharina Achstetter ORCID, Reinhard Busse ORCID
Int J Health Policy Manag. 2020;9(9): 370-379. doi: 10.15171/ijhpm.2019.141
PMCID: PMC7557428     PMID: 32610712    
Article
PDF
XML
Cited By:
Original Article

19. Comparing 3 Approaches for Making Vaccine Adoption Decisions in Thailand
Waranya Rattanavipapong* ORCID, Ritika Kapoor, Yot Teerawattananon, Jos Luttjeboer, Siobhan Botwright, Rachel A. Archer, Birgitte Giersing, Raymond C. W. Hutubessy
Int J Health Policy Manag. 2020;9(10): 439-447. doi: 10.15171/ijhpm.2020.01
PMCID: PMC7719214     PMID: 32610741    
Article
PDF
Suppl 1
Suppl 2
XML
Cited By:
Original Article

20. Fostering Responsible Innovation in Health: An Evidence-Informed Assessment Tool for Innovation Stakeholders
Hudson P. Silva ORCID, Andrée-Anne Lefebvre ORCID, Robson R. Oliveira ORCID, Pascale Lehoux* ORCID
Int J Health Policy Manag. 2021;10(4): 181-191. doi: 10.34172/ijhpm.2020.34
PMCID: PMC8167270     PMID: 32610749    
Article
PDF
XML
Cited By:
Commentary

21. Early Health Economic Modelling – Optimizing Development for Medical Device Developers? Comment on “Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling”
Conor Teljeur*, Máirín Ryan
Int J Health Policy Manag. 2020;9(9): 403-405. doi: 10.15171/ijhpm.2019.136
PMCID: PMC7557429     PMID: 32610765    
Article
PDF
XML
Cited By:
Commentary

22. It’s Not the Model, It’s the Way You Use It: Exploratory Early Health Economics Amid Complexity Comment on “Problems and Promises of Health Technologies: The Role of Early Health Economic Modelling”
Andrew Partington* ORCID, Jonathan Karnon ORCID
Int J Health Policy Manag. 2021;10(1): 36-38. doi: 10.15171/ijhpm.2020.04
PMCID: PMC7947702     PMID: 32610772    
Article
PDF
XML
Cited By:
Commentary

23. The Potential for Early Health Economic Modelling in Health Technology Assessment and Reimbursement Decision-Making Comment on “Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling”
Hansoo Kim* ORCID, Stephen Goodall, Danny Liew
Int J Health Policy Manag. 2021;10(2): 98-101. doi: 10.15171/ijhpm.2020.17
PMCID: PMC7947661     PMID: 32610777    
Article
PDF
XML
Cited By:
Commentary

24. Expanding the Role of Early Health Economic Modelling in Evaluation of Health Technologies Comment on “Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling”
Carlo Federici ORCID, Aleksandra Torbica* ORCID
Int J Health Policy Manag. 2021;10(2): 102-105. doi: 10.15171/ijhpm.2020.18
PMCID: PMC7947662     PMID: 32610778    
Article
PDF
XML
Cited By:
Commentary

25. Deliberative Processes by Health Technology Assessment Agencies: A Reflection on Legitimacy, Values and Patient and Public Involvement Comment on “Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe”
Mireille Goetghebeur* ORCID, Marjo Cellier
Int J Health Policy Manag. 2021;10(4): 228-231. doi: 10.34172/ijhpm.2020.46
PMCID: PMC8167272     PMID: 32610794    
Article
PDF
XML
Cited By:
Original Article

26. A Process for Evaluating Quality Decision-Making Practices During the Development, Review and Reimbursement of Medicines
Magdalena Bujar* ORCID, Neil McAuslane, Stuart Walker, Sam Salek
Int J Health Policy Manag. 2022;11(2): 128-137. doi: 10.34172/ijhpm.2020.86
PMCID: PMC9278608     PMID: 32610811    
Article
PDF
Suppl 1
Suppl 2
XML
Cited By:
Short Communication

27. Experiences of Using Cochrane Systematic Reviews by Local HTA Units
Thomas G. Poder* ORCID, Marc Rhainds ORCID, Christian A. Bellemare ORCID, Simon Deblois ORCID, Imane Hammana ORCID, Catherine Safianyk ORCID, Sylvie St-Jacques ORCID, Pierre Dagenais ORCID
Int J Health Policy Manag. 2022;11(2): 112-117. doi: 10.34172/ijhpm.2020.133
PMCID: PMC9278610     PMID: 32772006    
Article
PDF
XML
Cited By:
Commentary

28. Evidence-Informed Deliberative Processes for HTA Around the Globe: Exploring the Next Frontiers of HTA and Best Practices Comment on “Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe”

Unni Gopinathan* ORCID, Trygve Ottersen, Pascale-Renée Cyr, Kalipso Chalkidou ORCID
Int J Health Policy Manag. 2021;10(4): 232-236. doi: 10.34172/ijhpm.2020.145
PMCID: PMC8167266     PMID: 32772012    
Article
PDF
XML
Cited By:
Original Article

29. Ethical and Social Values for Paediatric Health Technology Assessment and Drug Policy
Avram E. Denburg* ORCID, Mita Giacomini, Wendy Ungar, Julia Abelson ORCID
Int J Health Policy Manag. 2022;11(3): 374-382. doi: 10.34172/ijhpm.2020.144
PMCID: PMC9278467     PMID: 32801223    
Article
PDF
XML
Cited By:
Original Article

30. Affordability of Medication Therapy in Diabetic Patients: A Scenario-Based Assessment in Iran’s Health System Context
Leila Zarei ORCID, Payam Peymani, Najmeh Moradi* ORCID, Mehrnaz Kheirandish ORCID, Mahtabalsadat Mirjalili ORCID, Marziyeh Zare ORCID
Int J Health Policy Manag. 2022;11(4): 443-452. doi: 10.34172/ijhpm.2020.152
PMCID: PMC9309945     PMID: 32861229    
Article
PDF
Suppl 1
Suppl 2
XML
Cited By:
Original Article

31. A Framework to Determine the Extent to Which Regional Primary Healthcare Organisations Are Comprehensive or Selective in Their Approach
Sara Javanparast* ORCID, Fran Baum ORCID, Anna Ziersch ORCID, Toby Freeman ORCID
Int J Health Policy Manag. 2022;11(4): 479-488. doi: 10.34172/ijhpm.2020.182
PMCID: PMC9309948     PMID: 33059425    
Article
PDF
Suppl 1
XML
Cited By:
Original Article

32. The Role of Regulator-Imposed Post-Approval Studies in Health Technology Assessments for Conditionally Approved Drugs
Rick A. Vreman ORCID, Lourens T. Bloem ORCID, Stijn van Oirschot, Jarno Hoekman, Menno E. van der Elst, Hubert GM Leufkens, Olaf H. Klungel, Wim G. Goettsch, Aukje K. Mantel-Teeuwisse* ORCID
Int J Health Policy Manag. 2022;11(5): 642-650. doi: 10.34172/ijhpm.2020.198
PMCID: PMC9309934     PMID: 33131224    
Article
PDF
Suppl 1
XML
Cited By:
Original Article

33. Exploring Community Mental Health Systems – A Participatory Health Needs and Assets Assessment in the Yamuna Valley, North India
Kaaren Mathias* ORCID, Meenal Rawat ORCID, Anna Thompson ORCID, Rakhal Gaitonde ORCID, Sumeet Jain ORCID
Int J Health Policy Manag. 2022;11(1): 90-99. doi: 10.34172/ijhpm.2020.222
PMCID: PMC9278393     PMID: 33300767    
Article
PDF
Suppl 1
XML
Cited By:
Original Article

34. District-Level Health Management and Health System Performance: The Ethiopia Primary Healthcare Transformation Initiative
Lingrui Liu ORCID, Mayur M. Desai ORCID, Netsanet Fetene ORCID, Temsgen Ayehu, Kidest Nadew ORCID, Erika Linnander* ORCID
Int J Health Policy Manag. 2022;11(7): 973-980. doi: 10.34172/ijhpm.2020.236
PMCID: PMC9808198     PMID: 33327692    
Article
PDF
XML
Cited By:
Original Article

35. Can the Use of Health Insurance Claim Data Benefit the Risk-Based Supervision of General Practitioner Practices? An Exploratory Study in the Netherlands
Rudolf Bertijn Kool* ORCID, Reinier Peter Akkermans, Ine Borghans, Corline Brouwers, Sander Ranke
Int J Health Policy Manag. 2022;11(7): 1009-1016. doi: 10.34172/ijhpm.2020.242
PMCID: PMC9808193     PMID: 33589565    
Article
PDF
XML
Cited By:
Original Article

36. Evidence-Informed Deliberative Processes for Legitimate Health Benefit Package Design − Part I: Conceptual Framework
Rob Baltussen* ORCID, Maarten Jansen ORCID, Wija Oortwijn ORCID
Int J Health Policy Manag. 2022;11(10): 2319-2326. doi: 10.34172/ijhpm.2021.158
PMCID: PMC9808261     PMID: 34923808    
Article
PDF
XML
Cited By:
Original Article

37. Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide
Wija Oortwijn* ORCID, Maarten Jansen ORCID, Rob Baltussen ORCID
Int J Health Policy Manag. 2022;11(10): 2327-2336. doi: 10.34172/ijhpm.2021.159
PMCID: PMC9808268     PMID: 34923809    
Article
PDF
Suppl 1
XML
Cited By:
Original Article

38. Developing a How-to-Guide for Health Technology Reassessment: “The HTR Playbook”

Lesley J.J. Soril ORCID, Adam G. Elshaug, Rosmin Esmail, Kalipso Chalkidou, Mohamed Gad, Fiona M. Clement*
Int J Health Policy Manag. 2022;11(11): 2525-2532. doi: 10.34172/ijhpm.2021.180
PMCID: PMC9818092     PMID: 35065545    
Article
PDF
Suppl 1
XML
Cited By:
Original Article

39. How to Evaluate Health in All Policies at the Local Level: Methodological Insights Within Municipalities From the WHO French Healthy Cities Network

Marion Porcherie* ORCID, Marie-Florence Thomas ORCID, Frédérique Quidu ORCID, Zoé Héritage, Zoé Vaillant ORCID, Jean Simos ORCID, Stéphane Rican ORCID, Nicola Cantoreggi ORCID, Emmanuelle Faure, Anne Roué Le Gall ORCID
Int J Health Policy Manag. 2022;11(12): 3060-3070. doi: 10.34172/ijhpm.2022.6584
PMCID: PMC10105196     PMID: 35942970    
Article
PDF
Suppl 1
Suppl 2
XML
Cited By:
Commentary

40. Challenges and Opportunities for Deliberative Processes for Healthcare Decision-Making Comment on “Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide”

Kenneth Bond* ORCID
Int J Health Policy Manag. 2023;12: 7458 | Published on: 2022 Aug 16. doi: 10.34172/ijhpm.2022.7458
PMCID: PMC10125176     PMID: 35988028    
Article
PDF
XML
Cited By:
Commentary

41. Three Approaches to Improve a Practical Guide on Evidence-Informed Deliberative Processes for Health Benefit Package Design Comment on “Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide”

Javier Guzman* ORCID
Int J Health Policy Manag. 2023;12: 7502 | Published on: 2022 Aug 31. doi: 10.34172/ijhpm.2022.7502
PMCID: PMC10125080     PMID: 36086853    
Article
PDF
XML
Cited By:
Original Article

42. Explaining Variations in Long-term Care Use and Expenditures Under the Public Long-term Care Insurance Systems: A Case Study Comparison of Korea and Japan
Hongsoo Kim ORCID, Nan-He Yoon ORCID, Youjin Hahn ORCID, Hideki Hashimoto* ORCID
Int J Health Policy Manag. 2023;12: 6640 | Published on: 2022 Nov 19. doi: 10.34172/ijhpm.2022.6640
PMCID: PMC10125049     PMID: 37579485    
Article
PDF
Suppl 1
Suppl 2
XML
Cited By:
Commentary

43. Moral and Social Values in Evidence-Informed Deliberative Processes for Health Benefit Package Design Comment on “Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide”
Michael J. DiStefano* ORCID
Int J Health Policy Manag. 2023;12: 7480 | Published on: 2022 Dec 28. doi: 10.34172/ijhpm.2022.7480
PMCID: PMC10125053     PMID: 37579447    
Article
PDF
XML
Cited By:
Commentary

44. Evidence-Informed Deliberative Processes for UHC: Progress, Potential and Prudence Comment on “Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide”

Unni Gopinathan* ORCID
Int J Health Policy Manag. 2023;12: 7541 | Published on: 2023 Feb 13. doi: 10.34172/ijhpm.2022.7541
PMCID: PMC10125249     PMID: 37579471    
Article
PDF
XML
Cited By:
Original Article

45. What, Where, and How to Collect Real-World Data and Generate Real-World Evidence to Support Drug Reimbursement Decision-Making in Asia: A reflection Into the Past and A Way Forward
Sarin Kc ORCID, Lydia Wenxin Lin, Diana Beatriz Samson Bayani, Yaroslava Zemlyanska ORCID, Amanda Adler, Jeonghoon Ahn, Kelvin Chan, Dechen Choiphel, Anne Julienne Genuino-Marfori, Brendon Kearney, Yuehua Liu, Ryota Nakamura, Fiona Pearce, Shankar Prinja, Raoh-Fang Pwu, Arsul Akmal Shafie ORCID, Binyan Sui, Auliya Suwantika ORCID, Sean Tunis, Hui-Min Wu, John Zalcberg, Kun Zhao, Wanrudee Isaranuwatchai ORCID, Yot Teerawattananon ORCID, Hwee-Lin Wee* ORCID
Int J Health Policy Manag. 2023;12: 6858 | Published on: 2023 Mar 06. doi: 10.34172/ijhpm.2023.6858
PMCID: PMC10461954     PMID: 37579427    
Article
PDF
XML
Cited By:
Original Article

46. Assessing Global Evidence on Cost-Effectiveness to Inform Development of Pakistan’s Essential Package of Health Services
Maryam Huda ORCID, Nichola Kitson, Nuru Saadi, Saira Kanwal, Urooj Gul, Maarten Jansen ORCID, Sergio Torres-Rueda ORCID, Rob Baltussen ORCID, Ala Alwan ORCID, Sameen Siddiqi ORCID, Anna Vassall* ORCID
Int J Health Policy Manag. 2024;13: 8005 | Published on: 2024 Jan 07. doi: 10.34172/ijhpm.2023.8005
Article
PDF
Suppl 1
Suppl 2
XML
Cited By:
Systematic Review

47. Institutional Priority-Setting for Novel Drugs and Therapeutics: A Qualitative Systematic Review
Daniel E. Wang ORCID, Maram Hassanein, Yasmeen Razvi, Randi Zlotnik Shaul, Avram Denburg* ORCID
Int J Health Policy Manag. 2024;13: 7494 | Published on: 2024 Feb 10. doi: 10.34172/ijhpm.2024.7494
PMCID: PMC11016276     PMID: 38618836    
Article
PDF
Suppl 1
Suppl 2
Suppl 3
XML
Cited By: